The global central lab market was estimated at USD 2.6 Billion in 2021 and it is set to grow USD 4.2 Billion by 2030 with a modest CAGR of 6.1% during the prediction period 2022 to 2030.
The global central lab market was estimated at USD 2.6 Billion in 2021 and it is set to grow USD 4.2 Billion by 2030 with a modest CAGR of 6.1% during the prediction period 2022 to 2030.
Central labs are designed to provide services for supporting clinical trials for upcoming drugs, genetic testing services for various genetic diseases such as Parkinson’s, Alzheimer’s, sickle cell anemia, and microbiology testing services such as testing the kinetics and growth of different microbes. Increase in number of diseases, advancements in new therapies & drugs, and large number of research grants, proposals, and funding to develop new testing procedures by governments are factors that drive global central lab market. However, central lab logistics problems such as fluctuation in temperature of samples, stability problems such as purity, contamination, and stringent & complex government regulations are projected to hamper the growth of the global central lab market.
Get the sample copy of report@ https://www.novaoneadvisor.com/report/sample/6300
North America dominated the global central lab market in 2021. The trend is anticipated to continue during the forecast period due to increase in incidence of major chronic diseases and rise in outsourcing of central lab services. Europe is likely to be a highly lucrative market for the central lab market during the forecast period. It is projected to expand at a high CAGR during the forecast period.
| Report Scope | Details |
| Market Size By 2030 | USD 4.2 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 6.1% |
| Largest Market | North America |
| Fastest Growing Region | Asia Pacific |
| Companies Covered | ACM Global Central Lab, Barc Lab (Cerba Research), Bioscientia (Sonic Healthcare), Celerion, CIRION BioPharma Research, Clinical Reference Laboratory, Lab Corp/Covance, Eurofins Central Laboratory |
Central Lab Market: Drivers
Surge in the number of patients suffering and affected by different diseases such as cancer and circulatory diseases, increase in the number of clinical trials for the development of various drugs, rise in the number of cases & prevalent occurrence, and advancement in technology, new therapies, and drugs propel the growth of the global central lab market. Increase in the number of patients across the globe is a major factor boosting the growth of the global central lab market.
Rise in outsourcing by pharmaceutical and biotechnological companies is projected to drive the global central lab market during the forecast period.
Ask here for customization@ https://www.novaoneadvisor.com/report/customization/6300
Market Segmentation: Central Lab Market
In terms of product, the global central lab market has been classified into genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services, clinical research & trial services, and others. The biomarker services segment is projected to capture the largest share of the global central lab market during the forecast period.
Based on end user, the global central lab market has been categorized into pharmaceutical companies, biotechnology companies, and academic & research institutes. The pharmaceutical companies segment dominated the global central lab market in terms of revenue in 2020.
Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The report provides current and expected revenue (US$ Mn) for each of these segments from 2018 to 2030, considering 2020 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2030, along with market size estimations.
Regional Overview: Central Lab Market
In terms of region, the global central lab market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
The current and expected market revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2018 to 2030, with their CAGRs from 2022 to 2030
The study also offers a list of recommendations, highlights, and useful insights of the global central lab market, which would help new companies willing to enter the market and existing companies to increase market shares and in the decision-making process
Some of the prominent players in the Central Lab Market include:
- ACM Global Central Lab
- Barc Lab (Cerba Research)
- Bioscientia (Sonic Healthcare)
- Celerion
- CIRION BioPharma Research
- Clinical Reference Laboratory
- Lab Corp/Covance
- Eurofins Central Laboratory
- Frontage Laboratories, Inc.
- ICON Central Labs
- INTERLAB Central Lab Services
- InVitro International
- LabConnect
Market Segmentation
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:
Central Lab Market, by Product
- Genetic Services
- Biomarker Services
- Microbiology Services
- Anatomic Pathology/Histology
- Specimen Management & Storage
- Special Chemistry Services
- Clinical Research & Trial Services
- Ohers
Central Lab Market, by End User
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Institutes
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Click Here to View Full Report Table of Contents
Buy this Research Report@ https://www.novaoneadvisor.com/report/checkout/6300
You can place an order or ask any questions, please feel free to contact at sales@novaoneadvisor.com | +1 9197 992 333